Collage of microbes, bacteria, disease

Identifying Cardiac Autoantibody Biomarkers that Predict the Severity of Chagas Cardiomyopathy

ven, 10/09/2026 - 06:00
Chagas cardiomyopathy (ChCM) affects up to 30% of patients with chronic Chagas disease and lacks reliable biomarkers for severity and conduction abnormalities. We profiled cardiac autoantibodies using 2-dimensional gel electrophoresis and mass spectrometry, followed by enzyme-linked immunosorbent assay validation and machine learning analysis. Six autoantibodies linked to glycolysis, adenosine triphosphate metabolism, and sarcomere structure distinguished ChCM stages (area under the curve: 0.87;...

Azadirone- and gedunin-type limonoids from Carapa procera seeds and their in vitro antimicrobial and antiproliferative activities

dim, 10/04/2026 - 06:00
The phytochemical study of the ethyl acetate extract of Carapa procera seeds led to the identification of two new limonoids, an azadirone-type limonoid, 6α,17β-dihydroxyazadiradione (1) and a gedunin-type limonoid, (-)-5-epi-5-hydroxy-7-deacetoxy-7-oxogedunin (2), as well as eleven known compounds, 6α-hydroxyazadiradione (3), 6-deoxydetigloylswietenin (4), mexicanolide (5), 7-deacetylgedunin (6), khayasin (7), 14,15-didehydroruageanin A (8), 17β-hydroxyazadiradione (9), xylomexicanolide A (10),...

Flubendazole reduces emerging Dracunculus medinensis in dogs in Chad: Results from a two-year study

ven, 09/25/2026 - 06:00
Since being targeted for eradication in the 1980s, global human cases of dracunculiasis (Guinea worm disease; GWD) have been reduced by over 99.9% through interventions aimed at interrupting the life cycle of the causative parasite, Dracunculus medinensis. However, the burden of GWD in dogs is higher than in humans and other monitored mammalian host species, threatening eradication of GWD. Expanding on a previous clinical trial of flubendazole (FLBZ) in dogs in Chad, we conducted a...

Interventions facilitating access to perinatal care for migrant women without medical insurance: a scoping review

jeu, 09/10/2026 - 06:00
CONCLUSION: This scoping review highlighted interventions that facilitate access to perinatal care for migrant women without medical insurance. As the first of its kind, the findings reveal significant policy shifts that jeopardize the health benefits of undocumented immigrants and asylum seekers, contributing to profound health disparities. Further, these individuals may forgo necessary medical treatment, preventive care, and routine check-ups due to fear of detection and deportation.

Metabolomics Spectral Processing, Data Analysis, and Multiomics Integration Using MetaboAnalyst 6.0

mer, 09/02/2026 - 06:00
MetaboAnalyst is a comprehensive, user-friendly web-based platform for metabolomics data analysis and interpretation. It offers a unified analytical workflow with an intuitive interface designed to streamline data analysis for both targeted and untargeted metabolomics, while supporting integration with other omics datasets. MetaboAnalyst 6.0 represents a significant advancement toward this vision by supporting LC-MS raw spectral processing and MS2 spectral annotation. This chapter builds on our...

Using MetaboAnalyst 6.0 for exposomics data analysis-from LC-MS2 spectra processing to dose-response modeling and causal inference

mar, 08/18/2026 - 06:00
Exposomics is an emerging field of research that aims to comprehensively investigate individuals' environmental exposures and how these exposures relate to health outcomes. Liquid chromatography-tandem mass spectrometry is widely used in exposomics studies. MetaboAnalyst ( https://www.metaboanalyst.ca/ ) is a widely used platform for statistical and functional analysis of metabolomics data. The current MetaboAnalyst 6.0 release incorporates updates to meet the needs of exposomics studies,...

Guideline on treatment intensification with injectable therapies beyond GLP-1 RA based therapies in type 2 diabetes

dim, 08/02/2026 - 06:00
CONCLUSIONS: This guideline offers a framework for treatment intensification beyond GLP‑1 RA monotherapy in T2DM, emphasizing shared decision‑making based on glycemic goals, hypoglycemia risk, weight needs, and patient preferences.

Minimal supply chain and forecasting testing volumes for clinical bacteriology laboratories in resource-limited settings for individual patient care: a costing study

sam, 08/01/2026 - 06:00
BACKGROUND: Inadequate access to clinical bacteriology testing in low-resource settings compromises individual patient care and contributes to antimicrobial resistance. Funders, policy makers, and health administrators working to expand bacteriology testing in sub-Saharan Africa require evidence-based guidance. The aim of this study was to assemble a costed consensus list of minimum equipment and consumables required to implement and operate a functional clinical bacteriology laboratory in...

Genomic Diversity of Mycobacterium tuberculosis Complex in Tahiti, French Polynesia

jeu, 07/30/2026 - 06:00
Evolving genomic diversity of Mycobacterium tuberculosis complex pathogens is poorly known in French Polynesia, a remote archipelago in the southern Pacific Ocean. A total of 321 mycobacteria sampled from 321 patients presenting pulmonary tuberculosis between 1998 and 2010 at the microbiology laboratory of the French Polynesia Hospital Centre in Tahiti were whole genome sequenced (WGS), disclosing three major M. tuberculosis sensu stricto sublineages: L4.4.1.1 S-type, L4.1.1.3 X-Type, and...

Emergence of Babesiosis in Nova Scotia, Canada

mar, 07/28/2026 - 06:00
AbstractAs part of a multi-year surveillance program of tick-borne diseases, we describe babesia surveillance of blood donors using nucleic acid tests conducted in 2025 and summarize cases of babesiosis reported by public health officials in Nova Scotia, Canada, from 2023 through 2025. Among 10,976 blood donor specimens, one specimen, collected from a blood donor in Nova Scotia Health's Western Zone, was positive, although this result was unable to be confirmed. Since babesiosis became...

Health care providers' perspectives on barriers and enablers to providing hepatitis C screening and treatment for immigrants in Canada: A theory-informed qualitative study

lun, 07/06/2026 - 06:00
CONCLUSION: This study underscores the complex barriers health care providers face in delivering HCV care to immigrant populations in Canada. While some challenges reflect broader health care system gaps, they are compounded for immigrants by linguistic and cultural differences. Strengthening provider capacity, improving system coordination, and embedding culturally and linguistically responsive approaches are essential to advancing HCV elimination.

Flubendazole 2.0: Designing a large field trial in dogs for a challenging setting

jeu, 07/02/2026 - 06:00
Dracunculiasis, or Guinea worm disease (GWD), was targeted for eradication in 1986 after which, the annual incidence decreased by over 99.9%. As human cases of GWD near elimination, dogs have become the primary reservoir for the parasite and remain a challenge for eradication efforts. The high burden of GWD in dogs relative to humans highlights the need for therapeutic interventions in conjunction with behavioral interventions. Laboratory experiments in ferrets demonstrated that flubendazole is...

Acute myocardial infarction induces sex-specific, time-dependent remodeling of the gut microbiome and intestinal immune compartment in retired breeder C57BL/6N mice

mer, 06/24/2026 - 06:00
INTRODUCTION: The gut microbiome influences cardiovascular health through metabolite production and immune modulation. Gut microbial dynamics and cardiovascular outcomes are also shaped by biological sex. However, sex-specific responses to myocardial infarction (MI) that involve the gut microbiome and intestinal milieu remain poorly defined, particularly in older hosts. Here, we characterize gut microbiome structure and function alongside physiological and immune responses to MI across multiple...

Logos des partenaires du centre

 

 

Back to top